Clinical Trials List
Protocol NumberKEPIDA-4
Completed
2025-01-01 - 2028-06-30
Phase III
Recruiting1
ICD-10C19
Malignant neoplasm of rectosigmoid junction
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9154.0
Malignant neoplasm of rectosigmoid junction
-
Trial Applicant
GNT Biotech & Medicals Corporation,
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
102 participants
-
Global
NA participants
